NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Markets Attempt Rebound but Fail to Sustain Gains

The Indian markets experienced a tug of war between bulls and bears on May 22, as they attempted a sharp rebound but failed to sustain gains amid selling pressure at higher levels. The Nifty 50 eventually settled with a 0.40% gain at 23,703, while the Sensex closed at 75,425, up 0.36% from the previous close.

The broader markets remained mixed, with the Nifty Midcap 100 closing with a mild 0.15% gain, while the Nifty Smallcap 100 index slipped 0.12%. Key sectoral indices such as Nifty Private Bank, Nifty Metal, and Nifty Bank emerged as top gainers, advancing up to 1.40%. On the other hand, Nifty Media and Nifty Pharma were the top laggards, with each falling over 1%. Other indices such as Nifty IT and Nifty Oil & Gas also closed in the red.

Indian Rupee Extends Recovery Rally

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The Indian rupee extended its recovery rally, strengthening to 95.7 per dollar from its record low of 96.96 on May 20. The Reserve Bank of India continued intervening in the currency markets to support the rupee amid its decline this year. The central bank reportedly sold dollars to state-run banks through the third week of the month.

Commodity Market Remains Elevated

Crude oil prices remained elevated as conflicting statements from the US and Iran reinforced fears that supply disruptions could persist for longer. US President Donald Trump said on Thursday that the United States would eventually secure Iran's stockpile of highly enriched uranium, despite Iran stating that it would not hand over the material.

Earnings-Driven Momentum Lifts Select Stocks

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Minda Corporation emerged as the top performer among Nifty 500 stocks, surging 9% to ₹585 apiece. JSW Cement also posted a strong gain of 8.5% to ₹138.3 per share. Honasa Consumer shares ended with a solid 6% jump after the FMCG company reported its highest-ever operating profit and PAT since listing, while also announcing its maiden dividend of ₹3 per share for FY26.

StockGain (%)
Minda Corporation9%
JSW Cement8.5%
Honasa Consumer6%
Tata Communications3.2%
Sammaan Capital5%
Kaynes Technology India5%
Dixon Technologies4%
GAIL (India)2.8%
Firstsource Solutions6%
Meesho3.5%
Lenskart Solutions3.5%

Other stocks including Trent, Capri Global Capital, Shriram Finance, Page Industries, 3M India, Force Motors, and Concord Biotech closed with gains of over 2.5%.

Weak Earnings, OFS Trigger Sharp Selloff in Select Counters

Engineers India emerged as the worst performer, falling 9% to ₹216, as investors were disappointed with the company's March quarter performance. Meanwhile, Central Bank of India shares slipped 8% after the government launched its offer for sale (OFS) to divest up to an 8% stake in the lender at a discount to the previous closing price. Max Healthcare Institute also reacted negatively to its Q4 results, declining 6.2% to ₹1,023 apiece.

StockLoss (%)
Engineers India9%
Central Bank of India8%
Max Healthcare Institute6.2%
Glenmark Pharmaceuticals5.2%
Aurobindo Pharma5.2%
Eris Lifesciences3%
Pine Labs3.7%
Paytm3.6%

Other stocks such as Sai Life Sciences, Vijaya Diagnostic Centre, Thermax, LG Electronics India, and Deepak Nitrite closed with losses of over 2.5%.

Investor Takeaway

Markets attempted a sharp rebound but failed to sustain gains amid selling pressure.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.